000 | 01412 a2200409 4500 | ||
---|---|---|---|
005 | 20250511185121.0 | ||
264 | 0 | _c19930115 | |
008 | 199301s 0 0 eng d | ||
022 | _a0379-0363 | ||
024 | 7 |
_a10.1007/978-3-0348-7321-5_40 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAssfalg-Machleidt, I | |
245 | 0 | 0 |
_aThe role of the kininogens as cysteine proteinase inhibitors in local and systemic inflammation. _h[electronic resource] |
260 |
_bAgents and actions. Supplements _c1992 |
||
300 |
_a312-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aCathepsin B _xantagonists & inhibitors |
650 | 0 | 4 | _aCathepsin L |
650 | 0 | 4 |
_aCathepsins _xantagonists & inhibitors |
650 | 0 | 4 |
_aCystatins _xphysiology |
650 | 0 | 4 | _aCysteine Endopeptidases |
650 | 0 | 4 | _aEndopeptidases |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aInflammation _xphysiopathology |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aKininogens _xblood |
650 | 0 | 4 |
_aPapain _xantagonists & inhibitors |
700 | 1 | _aBilling, A | |
700 | 1 | _aFröhlich, D | |
700 | 1 | _aNast-Kolb, D | |
700 | 1 | _aJoka, T | |
700 | 1 | _aJochum, M | |
700 | 1 | _aMachleidt, W | |
773 | 0 |
_tAgents and actions. Supplements _gvol. 38 ( Pt 1) _gp. 312-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-0348-7321-5_40 _zAvailable from publisher's website |
999 |
_c1472769 _d1472769 |